SEARCH

SEARCH BY CITATION

References

  • 1
    Adlercreutz H,Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997; 29: 95120.
  • 2
    Trock BJ,Hilakivi-Clarke L,Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98: 45971.
  • 3
    Mishra SI,Dickerson V,Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J Obstet Gynecol 2003; 188(5 Suppl, ): S6670.
  • 4
    Setchell KD,Lawson AM,Borriello SP,Harkness R,Gordon H,Morgan DM,Kirk DN,Adlercreatz H,Anderson LC,Axelson M. Lignan formation in man–microbial involvement and possible roles in relation to cancer. Lancet 1981; 2: 47.
  • 5
    Adlercreutz H,Fotsis T,Heikkinen R,Dwyer JT,Woods M,Goldin BR,Gorbach SL. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982; 2: 12959.
  • 6
    Rose DP. Dietary fiber, phytoestrogens, and breast cancer. Nutrition 1992; 8: 4751.
  • 7
    Liu ZP,Yu B,Huo JS,Lu CQ,Chen JS. Estrogenic effects of Cimicifuga racemosa (black cohosh) in mice and on estrogen receptors in MCF-7 cells. J Med Food 2001; 4: 1718.
  • 8
    Matsumura A,Ghosh A,Pope GS,Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2005; 94: 43143.
  • 9
    Wang TT,Sathyamoorthy N,Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996; 17: 2715.
  • 10
    Diel P,Olff S,Schmidt S,Michna H. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7. Planta Med 2001; 67: 51014.
  • 11
    Ju YH,Allred CD,Allred KF,Karko KL,Doerge DR,Helferic W. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 2001; 131: 295762.
  • 12
    Amato P,Christophe S,Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002; 9: 14550.
  • 13
    Wu W-H,Liu L-Y,Chung C-J,Jou H-J,Wang T-A. Estrogenic effect of yam ingestion in healthy postmenopausal women. J Am Coll Nutr 2005; 24: 235243.
  • 14
    Nesselhut T,Schellhase R,Dietrich R,Kuhn W. Untersuchungen zur proliferativen Potenz von Phytopharmaka mit ostrogenahnlicher Wirkung bei Mammarkarzinomzellen. Gynakol Onkol 1993; 254: 81718.
  • 15
    Zierau O,Boinet C,Kolba S,Wulf M,Vollmer G. Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol 2002; 80: 12530.
  • 16
    Strom BL,Schinnar R,Weber AL,Bunin GR,Berlin JA,Baumgarten M,DeMichele AM,Rubin SC,Berlin M,Troxel AB,Rebbeck TR. Protective effect of postmenopausal use of combined estrogen plus progestin hormone therapy for endometrial cancer risk. Am J Epidemiol 164(8): 77586.
  • 17
    Rossouw JE,Anderson GL,Prentice RL,LaCroix AZ,Kooperberg C,Stefanick ML,Jackson RD,Beresford SA,Howard BV,Johnson KC,Kotchen JM,Ockene J, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 32133.
  • 18
    Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health-Syst Pharm 1999; 56: 14002.
  • 19
    Stoll W. Phytopharmacon influences atrophic vaginal epithelium: double-blind study—Cimicifuga vs estrogenic substances. Therapeuticum 1987; 1: 2331.
  • 20
    Lehmann-Willenbrock E,Riedel H. Clinical and endocrinological examinations concerning therapy of climacteric symptoms following hysterectomy with remaining ovaries. Zentralbl Gynakol 1988; 110: 61118.
  • 21
    Jacobson JS,Troxel AB,Evans J,Klaus L,Vahdat L,Kinne D,Lo KM,Moore A,Rosenman PJ,Kaufman EL,Neugut AI,Grann VR. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19: 273945.
  • 22
    Liu J,Burdette JE,Xu H,Gu C,van Breemen RB,Bhat KP,Booth N,Constantinou AI,Pezzuto JM,Fong HH,Farnsworth NR,Bolton JL. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001; 49: 24729.
  • 23
    Bodinet C,Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause 2004; 11: 2819.
  • 24
    Lupu R,Mehmi I,Atlas E,Tsai MS,Pisha E,Oketch-Rabah HA,Nuntanakorn P,Kennelly EJ,Kronenberg F. Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Oncol 2003; 23: 140712.
  • 25
    Einbond LS,Shimizu M,Xiao D,Nuntanakorn P,Lim JT,Suzui M,Seter C,Pertel T,Kennelly EJ,Kronenberg F,Weinstein IB. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res Treat 2004; 83: 22131.
  • 26
    Burdette JE,Chen SN,Lu ZZ,Xu H,White BE,Fabricant DS,Liu J,Fong HH,Farnsworth NR,Constantinou AI,Van Breemen RB,Pezzuto JM, et al. Black cohosh (Cimicifuga racemosa L.) protects against menadione-induced DNA damage through scavenging of reactive oxygen species: bioassay-directed isolation and characterization of active principles. J Agric Food Chem 2002; 50: 70228.
  • 27
    Appelt LC,Reicks MM. Soy induces phase II enzymes but does not inhibit dimethylbenz (a) anthracene-induced carcinogenesis in female rats. J Nutr 1999; 129: 18206.
  • 28
    Cohen SM,O'Connor AM,Hart J,Merel NH,Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 2004; 11: 5757.
  • 29
    Davis V,Jayo MJ,Hardy ML,Ho A,Lee H,Shaikh F,Foster CL,Hughes CL. Effects of black cohosh in MMTV-neu transgenic mice. Proc AACR 2003; 44: 208.